- Hospitaler/Afdelinger Se de enkelte afdelingers forskningsprofil
- Forskere Søg forskere og deres videnskabelige arbejde
- Publikationer Publikationer med forskere fra Region Hovedstaden
- Forskningsprojekter Søg projekter/clinical trials i Region Hovedstaden
- Aktiviteter Med forskere fra Region Hovedstaden
Forskning
Udskriv
Switch language
Region Hovedstaden
- en del af Københavns Universitetshospital
Udgivet
Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail
Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling › Forskning
Harvard
Hvistendahl, M 2019, Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail. Faculty of Health Sciences, University of Copenhagen.
APA
Hvistendahl, M. (2019). Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail. Faculty of Health Sciences, University of Copenhagen.
CBE
Hvistendahl M 2019. Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail. Faculty of Health Sciences, University of Copenhagen.
MLA
Hvistendahl, Mark Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail Faculty of Health Sciences, University of Copenhagen. 2019.
Vancouver
Hvistendahl M. Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail. Faculty of Health Sciences, University of Copenhagen, 2019.
Author
Bibtex
@phdthesis{d33c4501ac084c59afb96e19c40a6d73,
title = "Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail",
author = "Mark Hvistendahl",
year = "2019",
language = "English",
publisher = "Faculty of Health Sciences, University of Copenhagen",
}
RIS
TY - BOOK
T1 - Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail
AU - Hvistendahl, Mark
PY - 2019
Y1 - 2019
M3 - Ph.D. thesis
BT - Treatment with glepaglutide, a glucagon-like peptide-2 analog, in patients with short bowel syndrom - findings from a phase 2 trail
PB - Faculty of Health Sciences, University of Copenhagen
ER -
ID: 59435161